aiqbench analysis
This research introduces a conformal prediction framework specifically designed to handle label shift in molecular property prediction for drug discovery. By generating statistically rigorous uncertainty intervals without retraining, the method addresses critical reliability issues when experimental conditions diverge from training data. This advancement supports more trustworthy AI decision-making in high-stakes pharmaceutical pipelines where regulatory transparency is essential.
Conformal Prediction for Molecular Properties under Label Shift
arXiv:2608.17678v1 Announce Type: new Abstract: Drug discovery and development underpins healthcare but remains costly and failure-prone. A critical bottleneck lies in predicting molecular properties such as solubility, potency, and toxicity, which directly determine whether a candidate can advance from preclinical to clinical trials. Artificial Intelligence (AI) has accelerated this process, yet its reliability is often undermined by distribution shift, as experimental conditions frequently diverge from training data. In addition, conventional point predictions provide only single-value estimates, offering limited guidance for high-stakes experimental design. We address these challenges with a conformal prediction framework tailored to label shift. By weighting conformal scores using marginal label probability ratios, our method produces statistically rigorous prediction intervals without retraining. This enables robust uncertainty quantification even when property distributions drift, directly tackling one of the most pervasive obstacles to applying AI in real-world drug development. By moving beyond accuracy alone to provide actionable confidence measures, our approach enhances the trustworthiness of AI-driven predictions. This further aligns predictive modeling with regulatory demands for transparency and uncertainty reporting and ultimately supports more reliable decision-making in billion-dollar development pipelines.
Abstract:Drug discovery and development underpins healthcare but remains costly and failure-prone. A critical bottleneck lies in predicting molecular properties such as solubility, potency, and toxicity, which directly determine whether a candidate can advance from preclinical to clinical trials. Artificial Intelligence (AI) has accelerated this process, yet its reliability is often undermined by distribution shift, as experimental conditions frequently diverge from training data. In addition, conventional point predictions provide only single-value estimates, offering limited guidance for high-stakes experimental design. We address these challenges with a conformal prediction framework tailored to label shift. By weighting conformal scores using marginal label probability ratios, our method produces statistically rigorous prediction intervals without retraining. This enables robust uncertainty quantification even when property distributions drift, directly tackling one of the most pervasive obstacles to applying AI in real-world drug development. By moving beyond accuracy alone to provide actionable confidence measures, our approach enhances the trustworthiness of AI-driven predictions. This further aligns predictive modeling with regulatory demands for transparency and uncertainty reporting and ultimately supports more reliable decision-making in billion-dollar development pipelines.
Machine Learning (cs.LG)
arXiv:2608.17678 [cs.LG]
(or arXiv:2608.17678v1 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2608.17678 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 269 words
Related coverage
Split Conformal Prediction with Label-Shift-Adjusted Bayesian Scores
arXiv · Sep 14, 2026
Molecular Property Prediction under Structural Shift with Tabular Foundation Models
arXiv · Oct 1, 2026
Learning to Select Source Domains: Proxy-Rewarded Policy Optimization for Molecular OOD Generalization
arXiv · Sep 30, 2026

Molecular Dynamics Reveal Nanosecond Tubulin Conformational Shifts
Quantum Zeitgeist · Jul 14, 2026